Status:
COMPLETED
Objective, Passive Assessment of LRRK2 Carriers
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
Emerald Innovations
Michael J. Fox Foundation for Parkinson's Research
Conditions:
Parkinson Disease
Eligibility:
All Genders
50+ years
Brief Summary
The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wirele...
Eligibility Criteria
Inclusion
- At least 50 years of age
- Able and willing to provide informed consent
- English fluency
- U.S. resident
- LRRK2 G2019S gene carrier, determined by participation in VALOR-PD
- Mild parkinsonian signs, determined by modified Movement Disorder Society-Unifeid Parkinson's Disease Rating Scale (MDS-UPDRS) score from the most recent VALOR-PD visit
- Have WiFi in their residence
- Access to a smartphone or tablet
Exclusion
- Inability to complete study activities, as determined by the study team
- Any medical or psychiatric condition that, in the study team's judgement, would preclude participation
- Self-reported or VALOR-PD investigator determined Parkinson's disease
- Any movement disorder (e.g. essential tremor)
- Currently taking neuroleptics or other drugs known to cause parkinsonism
- Pregnancy
- Non-ambulatory status
- More than one ambulatory pet in the household\*
- More than two individuals in the household (not including participant)\*
- these criteria can be waived at the discretion of the investigators
Key Trial Info
Start Date :
April 27 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 7 2024
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05287620
Start Date
April 27 2022
End Date
May 7 2024
Last Update
June 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Rochester
Rochester, New York, United States, 14620